- Home
- INDP vs AQMS Comparison
INDP vs AQMS Comparison
Compare INDP & AQMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDP
- AQMS
- Stock Information
- Founded
- INDP 2000
- AQMS 2014
- Country
- INDP United States
- AQMS United States
- Employees
- INDP N/A
- AQMS N/A
- Industry
- INDP Biotechnology: Pharmaceutical Preparations
- AQMS Metal Fabrications
- Sector
- INDP Health Care
- AQMS Industrials
- Exchange
- INDP Nasdaq
- AQMS Nasdaq
- Market Cap
- INDP 6.0M
- AQMS 5.1M
- IPO Year
- INDP N/A
- AQMS 2015
- Fundamental
- Price
- INDP $2.60
- AQMS $3.75
- Analyst Decision
- INDP Strong Buy
- AQMS Buy
- Analyst Count
- INDP 2
- AQMS 1
- Target Price
- INDP $238.00
- AQMS $30.00
- AVG Volume (30 Days)
- INDP 14.7K
- AQMS 35.1K
- Earning Date
- INDP 08-13-2025
- AQMS 08-13-2025
- Dividend Yield
- INDP N/A
- AQMS N/A
- EPS Growth
- INDP N/A
- AQMS N/A
- EPS
- INDP N/A
- AQMS N/A
- Revenue
- INDP N/A
- AQMS N/A
- Revenue This Year
- INDP N/A
- AQMS N/A
- Revenue Next Year
- INDP N/A
- AQMS $550.00
- P/E Ratio
- INDP N/A
- AQMS N/A
- Revenue Growth
- INDP N/A
- AQMS N/A
- 52 Week Low
- INDP $3.21
- AQMS $3.37
- 52 Week High
- INDP $58.24
- AQMS $46.00
- Technical
- Relative Strength Index (RSI)
- INDP 18.83
- AQMS 44.14
- Support Level
- INDP $6.26
- AQMS $3.55
- Resistance Level
- INDP $6.65
- AQMS $4.35
- Average True Range (ATR)
- INDP 0.76
- AQMS 0.31
- MACD
- INDP -0.33
- AQMS 0.10
- Stochastic Oscillator
- INDP 2.84
- AQMS 38.78
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.
About AQMS Aqua Metals Inc.
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.